Hôpital Paul Brousse
Université Paris-Sud
René Adam
Resection or Transplant as 1st line treatment ?
What are the Keys of Decision ?
LRLT vs Resection. Lee et al L Surg Oncol 2009
OS DFS
When comparing the results DFS : a major item…
What are the Keys of Decision ?
1- DFS more than OS…
Surgical Resection vs. Transplantation
Yamamoto J et al. Cancer 1999;86:1151
When comparing the results 10-Yr Survival mandatory…
OS DFS
Hepatectomy
Transplantation
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
3- Cirrhosis or not Cirrhosis ?
Study Flow
• Local Ablation n = 1,550
• Segmental Resection n = 703
• Lobectomy (incl. extended resection) n = 619
• Transplant n = 1,117
16,209 Patients with HCC in SEER Database (2004-2007)
3,989 Patients
Include only patients who underwent surgical treatment.
Exclude patients with metastatic disease, no staging data.
Overall Survival with Cirrhosis
Overall Survival with Minimal Fibrosis
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
3- Cirrhosis or not Cirrhosis ?
4- Within Milan or Beyond ?
Within Milan
Beyond Milan
A large difference in DFS !…
No difference at all !…
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
3- Cirrhosis or not Cirrhosis ?
4- Within Milan or Beyond ?
5- Comparative results
Study N 5-year survival Mortality (%)
Iwatsuki (2000) 344 49 % –
Tamura (2001) 53 61 % –
Hemming (2001) 112 57 % 13
Jonas (2001) 120 59 % 1.7
Figueras (2001) 307 63 % –
Yao (2001) 60 75 % 1.4
Todo (2004) 316 69 % (3-y ) –
Gondolesi (2004) 36 45 % 22
Zavaglia (2005) 155 72 % 11
Takada (2006) 93 64 % –
Cherqui (2009) 18a 70 %b 0
Lee (2010) 78 68 % 5.1
Coelho (2009) 45 4 recurrences 0
a Salvage transplantation after resection
b From time of transplantation
Selected series of Liver Transplantation for
Hepatocellular Carcinoma since 2000
Study N 5-year survival (%) Mortality (%)
____________________3540___________________________________________
Zhou (2001) 1000 63 1.5
Grazi (2001) 264 42 4.9
Yamamoto (2001) 58 62 –
Poon (2002) 135 70 3.7
Wayne (2002) 249 41 –
Grazi (2003) 308 42 4.9
Ercolani (2003) 224 42 –
Hu (2005) 154 – –
Pawlik (2005) 300 27 5
Wu (2005) 161 (1991-96) 28 3.7
265 (1997–02) 34 0.4
Taura (2007) 166 46 4
Yamashita (2007) 59 71 –
Cherqui (2009) 67 72 4.5
Lee (2010) 130 52 0.8
Selected series of Hepatic Resection for
Hepatocellular Carcinoma since 2000
49,43%
62,09%
Mean 5-year survival (Resection vs Liver transplantation)
Selected series published since 2000 with 5-y survival available
1376 patients (11 series)
3386 patients ( 14 series)
P = 0.02
6,7%
3,3%
Postoperative Mortality (Resection vs Liver transplantation)
Selected series published since 2000 with PO mortality available
624 patients (8 series)
2780 patients (10 series)
p=0.28
1. What are the respective results of Resection and LT
for Small Single HCC (up to 5cm) ?
2. Is there a cut-off size for which Resection could be
preferred to LT ?
Adam et al, Ann Surg 2012
Consecutive series of 97 Resections and 101 LT for:
- Single HCC up to 5 cm
- in cirrhotic patients
- Operated by the same surgical team
Potential bias : more Child B/C expected in the LT group:
- Would penalize Transplantation compared to Resection
- No influence on the tumor outcome « per se »
(recurrence not influenced by liver function status…)
Resection vs LT in Small HCC
Paul Brousse Hospital 1990-2010
VARIABLES
GROUP R
n = 97
GROUP T
n = 101 p value
Post Operative death
(up to 2 months)
Yes 4 (4.1%) 3 (3%) 0.72
Post Op
Complications
≥ Grade 3 Clavien 18 (19.1%) 24 (24.7%) 0.35
Tumour recurrence Yes 60 (61.9%) 10 (10.9%) < 0.0001
Site of tumour
recurrence
Hepatic
Extrahepatic
Hepatic and
Extrahepatic
49 (50.5%)
2 (2.1%)
9 (9.3%)
3 (3%)
5 (5%)
2 (2%)
0.33
Present Status
Alive
Alive without Disease
54 (55.7%)
26 (26.8%)
59 (58.4%)
55 (54.5%)
0.7
< 0.0001
Post operative Outcome Resection vs Transplantation
for Single HCC ≤ 5 cm on Cirrhosis
Survival for Single HCC ≤ 5 cm on Cirrhosis
Overall Survival Disease-Free Survival
Adam et al, Ann Surg 2012
FACTOR AND GROUPS OVERALL PATIENT COHORT
p value RR CI 95%
ALL PATIENTS (n = 198)
Overall Survival
Resection group
Maximum Diameter of nodule at diagnosis ≥ 3 cm
Microvascular Invasion
Disease free survival
Resection group
Maximum Diameter of nodule at diagnosis ≥ 3 cm
Microvascular Invasion
0.002
0.0003
0.005
< 0.0001
0.0004
0.02
2.15
2.41
1.95
4.88
2.02
1.56
[1.32 ; 3.48]
[1.5 ; 3.87]
[1.23 ; 3.09]
[3.11 ; 7.66]
[1.37 ; 2.99]
[1.06 ; 2.31]
Multivariate analysis in patients who underwent resection (n = 97) or
transplantation (n = 101) for single HCC on cirrhotic liver up to 5 cm diameter
Is there a cut-off size for which Resection is
at least equivalent to Transplantation ?
Survival for Solitary HCC 3-5 cm on Cirrhosis
Overall Survival Disease-Free Survival
Adam et al, Ann Surg 2012
FACTOR AND GROUPS OVERALL PATIENT COHORT
p value RR CI 95%
ALL PATIENTS (n = 77)
Overall Survival
Resection group
Microvascular invasion
Disease free survival
Resection group
Microvascular invasion
0.0006
0.0042
< 0.0001
0.0196
3.59
2.34
6.96
1.83
[1.73 ; 7.44]
[1.31 ; 4.19]
[3.22 ; 15.04]
[1.1 ; 3.03]
Multivariate analysis in patients who underwent resection (n= 51)or
transplantation (n = 35) for single HCC on cirrhotic liver 3-5 cm diameter
Survival for Solitary HCC ≤ 3 cm on Cirrhosis
Overall Survival Disease-Free Survival
Adam et al, Ann Surg 2012
FACTOR AND GROUPS OVERALL PATIENT COHORT
p value RR CI 95%
ALL PATIENTS (n = 114)
Overall Survival
Resection group
Age > 60
Period before 2000
Disease free survival
Resection group
-
0.0049
0.0086
< 0.0001
-
2.78
2.72
4.35
-
[1.36 ; 5.67]
[1.29 ; 5.74]
[2.39 ; 7.92]
Multivariate analysis in patients who underwent resection (n= 47)or
transplantation (n = 68) for single HCC on cirrhotic liver < 3 cm diameter
Carcinome Hépatocellulaire : Résection ou Transplantation pour un CHC de petite taille
2011
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
3- Cirrhosis or not Cirrhosis ?
4- Within Milan or Beyond ?
5- Comparative results
6- Equity of access to cure with Salvage ?
Salvage transplantation : the solution ?
Resection as a bridge to LT
2 different situations…
Decision LT
Resection
LT
« Bridge » LT
« Salvage » LT
Resection 1st
Recurrence
LT
Resection and Salvage LT ?
Adam and coll, Ann Surg 2003
Overall Survival Disease-free Survival
Belghiti et al, Ann Surg 2003
Resection as a Bridge / Salvage to LT ?
Cherqui et al, Ann Surg 2009
Bridge Salvage
Log rank p= 0.17
73%
70%
68%
53%
84%
88%
Primary LT : 349
Secondary LT : 33
Secondary vs Primary Transplantation for HCC
Overall Survival
Secondary vs Primary Transplantation for HCC
Disease-free Survival
Log rank p= 0.015
70%
51%
65%
43%
81%
75%
Primary LT : 349
Secondary LT : 33
Yes because:
More technical challenging
Increased risk of recurrence
Decreased disease-free survival
Liver Resection: a risk for secondary LT ?
Is recurrence after Resection always
suitable for Transplant ?
Resection
2nd LT 1st LT
Decision LT Decision LT
Drop out
Recurrence Out of Milan
criteria
Life-threatening
GI Bleeding
Infected Ascites
Liver Failure
Drop out
CANDIDATES
ELECTED
Author
Adam
Margarit
DelGaudio
Cherqui
Fucks
Present S
Country
France
Spain
Italy
France
France
France
Year
2003
-
2008
2009
2010
2011
Res / Rec
98 /75
37
80 / 39
67 / 36
118 / 90
117/ 91
% LT
23%
27%
26%
61%
43%
36%
LT after Liver resection :
A low transplantability rate overall…
From 1996 to 2005, we treated 227 cirrhotic patients with HCC
transplantable: 80 LRs and 147 LTs of 293 listed for
transplantation. Among 80 patients eligible for transplantation
who underwent LR, 39 (49%) developed HCC recurrence and
12/39 (31%) of these patients presented HCC recurrence
outside Milan criteria. Only 10 of the 39 patients underwent LT,
a transplantation rate of 26% of patients with HCC recurrence.
26% Transplantability rate of recurrence !
12.5% Transplantability rate of all LR !
Transplantability rate is much lower
in practice than it is theoretically
expected :
Up to 50% of patients could loose
the chance to be transplanted…
Transplantability after Resection
The reality…
« This low salvage rate may represent a lost opportunity for a
number of patients who, had they received a primary transplant may
have had better long term survival. For these patients the potential
for cure has been lost »
« Therefore, if we are going to propose resection to the patient with
HCC and cirrhosis we are potentially treating the patient with an
option that gives this patient a greater chance of recurrence and a
questionable overall survival when compared to primary liver
transplantation »
Resection with possible LT vs Primary LT
Overall Survival
68%
59%
56%
32%
88%
84%
Log rank test, p<0.0001
Primary LT : 352
Primary resection ± LT : 115
From the time of LR
From the time of LT
Resection with possible LT vs Primary LT
Disease-free Survival at last follow up
65%
31%
54%
20%
82%
70%
Log rank test, p<0.0001
Primary LT : 352
Primary resection ± LT : 115
Multivariate Analysis on Patients Eligible for Transplant
Resected or Transplanted (n=466)
RRP IC 95%
Overall survival
Disease-free survival
No nodules > 3 2.030.0008
Max size > 30 mm 1.710.002
[1.34 ; 3.08]
[1.22 ; 2.40]
Resection + LT 1.910.02 [1.11 ; 3.28]
No nodules > 3 1.710.02
Max size > 30 mm 1.770.002
[1.09 ; 2.67]
[1.24 ; 2.52]
Resection + LT 1.910.02 [1.11 ; 3.28]
What are the Keys of Decision ?
1- DFS more than OS…
2- Survival at 10 years more than at 5 years…
3- Cirrhosis or not Cirrhosis ?
4- Within Milan or Beyond ?
5- Comparative results
6- Equity of access to cure with Salvage ?
7- Could organ shortage justify all strategies ?
Shortage of Organs…
1- A living donor could sometimes be available…
2- Even not available, results of LT for HCC within
Milan criteria are as good as that of Benign disease
So….
Why to penalize patients with transplantatble HCC
precluding 80% of them from a possibility of long term
survival if not cure ?…
Yes but…
et al
CONCLUSIONS
1- Although liver resection may provide good survival benefit to
hyperselected patients, LT is overall the best option at long
term and on a disease-free basis
2- Resection provides similar survival only for single HCC< 3 cm
with however a lower disease-free survival compared to LT
3- Salvage transplantation is not the solution since a significant
proportion of pts loose the chance to be transplanted…
4- Provided that the survival benefit of HCC patients is similar to
that of ESLD, there is no ethical reason to discriminate HCC…

More Related Content

PPTX
En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...
PDF
Les Alternative à la Transplantation Hépatique Cadavérique
PPTX
Cancers hépatiques métastatiques : Actualité 2013-2014
PPTX
Radiologieinterventionnellechctdebaere
PDF
Liver Transplantation with severe steatotic graft and postoperative organ dys...
PPTX
Innovations in liver surgery for Hepatocellular Carcinoma
PPTX
Les outils d'évaluation ( Volumetries, Pressions) - Dr Andrea Laurenzi - Pr ...
PDF
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosis
En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...
Les Alternative à la Transplantation Hépatique Cadavérique
Cancers hépatiques métastatiques : Actualité 2013-2014
Radiologieinterventionnellechctdebaere
Liver Transplantation with severe steatotic graft and postoperative organ dys...
Innovations in liver surgery for Hepatocellular Carcinoma
Les outils d'évaluation ( Volumetries, Pressions) - Dr Andrea Laurenzi - Pr ...
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosis

What's hot (20)

PPTX
Hepatectomie en 2 temps - Pr René Adam
PDF
Liver Transplantation for Cholangiocarcinoma
PDF
Liver Transplantation in the setting of HIV infection
PPT
From Binge Drinking to Alcoholic Liver Disease - Du Binge Drinking à l'Hépati...
PDF
How to predict po course before and during surgery for HCC
PDF
Traitement Chirurgical HCC Conf Zurich
PDF
Resection early hcc
PDF
Chirurgie ouverte ou laparoscopique du foie : comment définir les limites ? -...
PDF
Innovation in Liver Surgery
PDF
Surgery at the Borderline in HCC patient - EASL Conference - Vienna 2015
PDF
Arterial Lactate Concentration is a major pronostic factor after elective sur...
PPTX
Quels impact de l'hépatopathie sous jacente? - Dr Andrea Laurenzi
PPT
Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015
PPT
Donor specific HLA alloantibodies and Hepatitis C Virus in Liver Transplantat...
PDF
New Technologies in Liver Laparoscopic Surgery
PDF
Portal Vein Embolization and colorectal liver met
PDF
Omata et al., 2017
PPT
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®
PPT
Costo efficacia della terapia con sorafenib nel trattamento dell’HCC - Gastro...
PPTX
Advances in cholangiocarcinoma
Hepatectomie en 2 temps - Pr René Adam
Liver Transplantation for Cholangiocarcinoma
Liver Transplantation in the setting of HIV infection
From Binge Drinking to Alcoholic Liver Disease - Du Binge Drinking à l'Hépati...
How to predict po course before and during surgery for HCC
Traitement Chirurgical HCC Conf Zurich
Resection early hcc
Chirurgie ouverte ou laparoscopique du foie : comment définir les limites ? -...
Innovation in Liver Surgery
Surgery at the Borderline in HCC patient - EASL Conference - Vienna 2015
Arterial Lactate Concentration is a major pronostic factor after elective sur...
Quels impact de l'hépatopathie sous jacente? - Dr Andrea Laurenzi
Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015
Donor specific HLA alloantibodies and Hepatitis C Virus in Liver Transplantat...
New Technologies in Liver Laparoscopic Surgery
Portal Vein Embolization and colorectal liver met
Omata et al., 2017
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®
Costo efficacia della terapia con sorafenib nel trattamento dell’HCC - Gastro...
Advances in cholangiocarcinoma
Ad

Viewers also liked (17)

PPTX
Embolisation portale - Dr Fernando Alvarez - Pr Denis Castaing
PPTX
Quoi de neuf chirurgie pancréatique? - Dr Daniel Pietraz
PPTX
Chirurgie : Quels indicateurs de qualité ? - Dr Gabriella Pittau
PPTX
Carcinome Hépato-Cellulaire : Actualité 2013-2014
PPTX
Prise en charge des complications post opératoire - Dr Gabriella Pittau
PPTX
Radiofréquence combinée à la résection - Dr Gabriella pittau - Pr Antoni...
PPTX
Quoi de neuf dans les tumeurs primitives du foie ? - Dr Eric Vibert
PPTX
Les moyens peropératoires de prévention de l'IHC - Dr Oriana Ciacio
PPTX
Quoi de neuf en chirurgie biliaire - Dr Oriana Ciacio
PPTX
Quoi de neuf dans les metastases ? - Dr Marc-Anoine Allard
PPTX
Fréquence et impact de l'IHC post-opératoire dans les hépatectomies - Dr N...
PPTX
Cholangiocarcinome Hilaire : Quelle préparation pour l'intervention?
PPT
Métastases Hépatique : Chirurgie ou chimiothérapie première? Résection en 1 o...
PPTX
Cholangiocarcinome Hilaire : Imagerie pré-opératoire
PPTX
Fistules Biliaires : Traitement chirurgical et résultats
PPTX
Tumeurs kystiques du pancréas : Quels malades opérer?
PPT
Tumeurs kystiques du pancréas : Comment orienter le dignostic en imagerie?
Embolisation portale - Dr Fernando Alvarez - Pr Denis Castaing
Quoi de neuf chirurgie pancréatique? - Dr Daniel Pietraz
Chirurgie : Quels indicateurs de qualité ? - Dr Gabriella Pittau
Carcinome Hépato-Cellulaire : Actualité 2013-2014
Prise en charge des complications post opératoire - Dr Gabriella Pittau
Radiofréquence combinée à la résection - Dr Gabriella pittau - Pr Antoni...
Quoi de neuf dans les tumeurs primitives du foie ? - Dr Eric Vibert
Les moyens peropératoires de prévention de l'IHC - Dr Oriana Ciacio
Quoi de neuf en chirurgie biliaire - Dr Oriana Ciacio
Quoi de neuf dans les metastases ? - Dr Marc-Anoine Allard
Fréquence et impact de l'IHC post-opératoire dans les hépatectomies - Dr N...
Cholangiocarcinome Hilaire : Quelle préparation pour l'intervention?
Métastases Hépatique : Chirurgie ou chimiothérapie première? Résection en 1 o...
Cholangiocarcinome Hilaire : Imagerie pré-opératoire
Fistules Biliaires : Traitement chirurgical et résultats
Tumeurs kystiques du pancréas : Quels malades opérer?
Tumeurs kystiques du pancréas : Comment orienter le dignostic en imagerie?
Ad

Similar to Carcinome Hépatocellulaire : Résection ou Transplantation pour un CHC de petite taille (20)

PPT
Early liver transplantation after resection for hcc
PPT
Liver transplantation for cancer
PPT
Surgical treatment of hepatocellular carcinoma
PPT
Surgical treatment of hepatocellular carcinoma.(Dr Juan Carlos Meneu Diaz). O...
PPT
Epatocarcinoma: trapianto o resezione? A chi e perche? - Gastrolearning®
PPT
Role of Surgery
PPT
Adjuvant therapy protocols for liver cancer in patients undergoing liver tran...
PPT
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
PPTX
SURGICAL Mx of HCC 2021 . Dr ZEKI Abdurahman Abubeker
PPT
Hepatocellular cancer ,liver cancer .
PPTX
Liver cancer final3
PDF
Liver transplantation results for hepatocellular carcinoma in chile
PPT
MCC 2011 - Slide 27
PPTX
Treatment of liver tumours current trends
PDF
Long Term Survival RF Ablation for Primary and Metastatic Liver Tumors
PDF
Long term survival radiofrequency ablation for primary and metastatic liver t...
PPT
S. Cascinu - Liver/Hepatobiliary - State of the art
PPTX
Hepatocellular Carcinoma(HCC): Treatment option
PPT
recent advances in hepatobiliary and GI surgery
Early liver transplantation after resection for hcc
Liver transplantation for cancer
Surgical treatment of hepatocellular carcinoma
Surgical treatment of hepatocellular carcinoma.(Dr Juan Carlos Meneu Diaz). O...
Epatocarcinoma: trapianto o resezione? A chi e perche? - Gastrolearning®
Role of Surgery
Adjuvant therapy protocols for liver cancer in patients undergoing liver tran...
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
SURGICAL Mx of HCC 2021 . Dr ZEKI Abdurahman Abubeker
Hepatocellular cancer ,liver cancer .
Liver cancer final3
Liver transplantation results for hepatocellular carcinoma in chile
MCC 2011 - Slide 27
Treatment of liver tumours current trends
Long Term Survival RF Ablation for Primary and Metastatic Liver Tumors
Long term survival radiofrequency ablation for primary and metastatic liver t...
S. Cascinu - Liver/Hepatobiliary - State of the art
Hepatocellular Carcinoma(HCC): Treatment option
recent advances in hepatobiliary and GI surgery

More from Centre Hepato-Biliaire / AP-HP Hopital Paul Brousse (20)

PPTX
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
PPTX
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
PPTX
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
PPTX
Point de vue du chirurgien hépatique - M.A. Allard
PPTX
Quoi de neuf dans les cancers primitifs du foie? - E. Vibert
PPTX
Conférence du Président d'honneur : l'échinococcose alvéolaire - G. Mansson
PPTX
Chirurgie guidée par la fluorescence - N. Golse
PPTX
Chirurgie de réduction tumorale des métastases hépatique non résécables de fa...
PPTX
Déprivation veineuse portale et sus-hépatique. Indications actuelles et résul...
PPTX
Point de vue du chirurgien colorectal - S. Benoist
PPTX
Chirurgie hépatique sous perfusion hypothermique - D. Azoulay
PPTX
Transplantation hépatique pour cancer: quelles tumeurs. A quelles conditions?...
PPT
DPC par chirurgie mini-invasive: Où en sommes-nous? C. Salloum
PPTX
Quoi de neuf dans les métastases hépatique?
PPTX
Destruction tumorale par écho-guidage optimisé - M.A. Allard
PPTX
Obésité et chirurgie HPB? Quels risques? Quelles recommandations? Quelle pris...
PPTX
Quoi de neuf dans les cancers du pancréas? - G. Pittau
PDF
Quand l'intelligence artificielle s'invite au bloc opératoire Eric VIbert.pdf
PDF
PDF
En Recherche Jean Charles Duclos Vallée.pdf
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
Situations difficiles en chirurgie biliaire : Présentations de trois cas clin...
Point de vue du chirurgien hépatique - M.A. Allard
Quoi de neuf dans les cancers primitifs du foie? - E. Vibert
Conférence du Président d'honneur : l'échinococcose alvéolaire - G. Mansson
Chirurgie guidée par la fluorescence - N. Golse
Chirurgie de réduction tumorale des métastases hépatique non résécables de fa...
Déprivation veineuse portale et sus-hépatique. Indications actuelles et résul...
Point de vue du chirurgien colorectal - S. Benoist
Chirurgie hépatique sous perfusion hypothermique - D. Azoulay
Transplantation hépatique pour cancer: quelles tumeurs. A quelles conditions?...
DPC par chirurgie mini-invasive: Où en sommes-nous? C. Salloum
Quoi de neuf dans les métastases hépatique?
Destruction tumorale par écho-guidage optimisé - M.A. Allard
Obésité et chirurgie HPB? Quels risques? Quelles recommandations? Quelle pris...
Quoi de neuf dans les cancers du pancréas? - G. Pittau
Quand l'intelligence artificielle s'invite au bloc opératoire Eric VIbert.pdf
En Recherche Jean Charles Duclos Vallée.pdf

Recently uploaded (20)

PDF
Diabetes mellitus - AMBOSS.pdf
PPTX
Hyperthyroidism, Thyrotoxicosis, Grave's Disease with MCQs.pptx
PPTX
Tuberculosis : NTEP and recent updates (2024)
PPTX
Genetics and health: study of genes and their roles in inheritance
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PPTX
Applied anatomy and physiology of Esophagus .pptx
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PPTX
Computed Tomography: Hardware and Instrumentation
PPT
fiscal planning in nursing and administration
PPTX
Acute Abdomen and its management updates.pptx
PPTX
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
PPTX
Nutrition needs in a Surgical Patient.pptx
PPTX
SEMINAR 6 DRUGS .pptxgeneral pharmacology
PPTX
presentation on dengue and its management
PPTX
Journal Article Review - Ankolysing Spondylitis - Dr Manasa.pptx
Diabetes mellitus - AMBOSS.pdf
Hyperthyroidism, Thyrotoxicosis, Grave's Disease with MCQs.pptx
Tuberculosis : NTEP and recent updates (2024)
Genetics and health: study of genes and their roles in inheritance
Local Anesthesia Local Anesthesia Local Anesthesia
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
intrduction to nephrologDDDDDDDDDy lec1.ppt
Approach to Abdominal trauma Gemme(COMMENT).pptx
Applied anatomy and physiology of Esophagus .pptx
periodontaldiseasesandtreatments-200626195738.pdf
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Biostatistics Lecture Notes_Dadason.pptx
Computed Tomography: Hardware and Instrumentation
fiscal planning in nursing and administration
Acute Abdomen and its management updates.pptx
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
Nutrition needs in a Surgical Patient.pptx
SEMINAR 6 DRUGS .pptxgeneral pharmacology
presentation on dengue and its management
Journal Article Review - Ankolysing Spondylitis - Dr Manasa.pptx

Carcinome Hépatocellulaire : Résection ou Transplantation pour un CHC de petite taille

  • 1. Hôpital Paul Brousse Université Paris-Sud René Adam Resection or Transplant as 1st line treatment ?
  • 2. What are the Keys of Decision ?
  • 3. LRLT vs Resection. Lee et al L Surg Oncol 2009
  • 4. OS DFS When comparing the results DFS : a major item…
  • 5. What are the Keys of Decision ? 1- DFS more than OS…
  • 6. Surgical Resection vs. Transplantation Yamamoto J et al. Cancer 1999;86:1151 When comparing the results 10-Yr Survival mandatory… OS DFS Hepatectomy Transplantation
  • 7. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years…
  • 8. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years… 3- Cirrhosis or not Cirrhosis ?
  • 9. Study Flow • Local Ablation n = 1,550 • Segmental Resection n = 703 • Lobectomy (incl. extended resection) n = 619 • Transplant n = 1,117 16,209 Patients with HCC in SEER Database (2004-2007) 3,989 Patients Include only patients who underwent surgical treatment. Exclude patients with metastatic disease, no staging data.
  • 11. Overall Survival with Minimal Fibrosis
  • 12. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years… 3- Cirrhosis or not Cirrhosis ? 4- Within Milan or Beyond ?
  • 13. Within Milan Beyond Milan A large difference in DFS !… No difference at all !…
  • 14. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years… 3- Cirrhosis or not Cirrhosis ? 4- Within Milan or Beyond ? 5- Comparative results
  • 15. Study N 5-year survival Mortality (%) Iwatsuki (2000) 344 49 % – Tamura (2001) 53 61 % – Hemming (2001) 112 57 % 13 Jonas (2001) 120 59 % 1.7 Figueras (2001) 307 63 % – Yao (2001) 60 75 % 1.4 Todo (2004) 316 69 % (3-y ) – Gondolesi (2004) 36 45 % 22 Zavaglia (2005) 155 72 % 11 Takada (2006) 93 64 % – Cherqui (2009) 18a 70 %b 0 Lee (2010) 78 68 % 5.1 Coelho (2009) 45 4 recurrences 0 a Salvage transplantation after resection b From time of transplantation Selected series of Liver Transplantation for Hepatocellular Carcinoma since 2000
  • 16. Study N 5-year survival (%) Mortality (%) ____________________3540___________________________________________ Zhou (2001) 1000 63 1.5 Grazi (2001) 264 42 4.9 Yamamoto (2001) 58 62 – Poon (2002) 135 70 3.7 Wayne (2002) 249 41 – Grazi (2003) 308 42 4.9 Ercolani (2003) 224 42 – Hu (2005) 154 – – Pawlik (2005) 300 27 5 Wu (2005) 161 (1991-96) 28 3.7 265 (1997–02) 34 0.4 Taura (2007) 166 46 4 Yamashita (2007) 59 71 – Cherqui (2009) 67 72 4.5 Lee (2010) 130 52 0.8 Selected series of Hepatic Resection for Hepatocellular Carcinoma since 2000
  • 17. 49,43% 62,09% Mean 5-year survival (Resection vs Liver transplantation) Selected series published since 2000 with 5-y survival available 1376 patients (11 series) 3386 patients ( 14 series) P = 0.02
  • 18. 6,7% 3,3% Postoperative Mortality (Resection vs Liver transplantation) Selected series published since 2000 with PO mortality available 624 patients (8 series) 2780 patients (10 series) p=0.28
  • 19. 1. What are the respective results of Resection and LT for Small Single HCC (up to 5cm) ? 2. Is there a cut-off size for which Resection could be preferred to LT ? Adam et al, Ann Surg 2012
  • 20. Consecutive series of 97 Resections and 101 LT for: - Single HCC up to 5 cm - in cirrhotic patients - Operated by the same surgical team Potential bias : more Child B/C expected in the LT group: - Would penalize Transplantation compared to Resection - No influence on the tumor outcome « per se » (recurrence not influenced by liver function status…) Resection vs LT in Small HCC Paul Brousse Hospital 1990-2010
  • 21. VARIABLES GROUP R n = 97 GROUP T n = 101 p value Post Operative death (up to 2 months) Yes 4 (4.1%) 3 (3%) 0.72 Post Op Complications ≥ Grade 3 Clavien 18 (19.1%) 24 (24.7%) 0.35 Tumour recurrence Yes 60 (61.9%) 10 (10.9%) < 0.0001 Site of tumour recurrence Hepatic Extrahepatic Hepatic and Extrahepatic 49 (50.5%) 2 (2.1%) 9 (9.3%) 3 (3%) 5 (5%) 2 (2%) 0.33 Present Status Alive Alive without Disease 54 (55.7%) 26 (26.8%) 59 (58.4%) 55 (54.5%) 0.7 < 0.0001 Post operative Outcome Resection vs Transplantation for Single HCC ≤ 5 cm on Cirrhosis
  • 22. Survival for Single HCC ≤ 5 cm on Cirrhosis Overall Survival Disease-Free Survival Adam et al, Ann Surg 2012
  • 23. FACTOR AND GROUPS OVERALL PATIENT COHORT p value RR CI 95% ALL PATIENTS (n = 198) Overall Survival Resection group Maximum Diameter of nodule at diagnosis ≥ 3 cm Microvascular Invasion Disease free survival Resection group Maximum Diameter of nodule at diagnosis ≥ 3 cm Microvascular Invasion 0.002 0.0003 0.005 < 0.0001 0.0004 0.02 2.15 2.41 1.95 4.88 2.02 1.56 [1.32 ; 3.48] [1.5 ; 3.87] [1.23 ; 3.09] [3.11 ; 7.66] [1.37 ; 2.99] [1.06 ; 2.31] Multivariate analysis in patients who underwent resection (n = 97) or transplantation (n = 101) for single HCC on cirrhotic liver up to 5 cm diameter
  • 24. Is there a cut-off size for which Resection is at least equivalent to Transplantation ?
  • 25. Survival for Solitary HCC 3-5 cm on Cirrhosis Overall Survival Disease-Free Survival Adam et al, Ann Surg 2012
  • 26. FACTOR AND GROUPS OVERALL PATIENT COHORT p value RR CI 95% ALL PATIENTS (n = 77) Overall Survival Resection group Microvascular invasion Disease free survival Resection group Microvascular invasion 0.0006 0.0042 < 0.0001 0.0196 3.59 2.34 6.96 1.83 [1.73 ; 7.44] [1.31 ; 4.19] [3.22 ; 15.04] [1.1 ; 3.03] Multivariate analysis in patients who underwent resection (n= 51)or transplantation (n = 35) for single HCC on cirrhotic liver 3-5 cm diameter
  • 27. Survival for Solitary HCC ≤ 3 cm on Cirrhosis Overall Survival Disease-Free Survival Adam et al, Ann Surg 2012
  • 28. FACTOR AND GROUPS OVERALL PATIENT COHORT p value RR CI 95% ALL PATIENTS (n = 114) Overall Survival Resection group Age > 60 Period before 2000 Disease free survival Resection group - 0.0049 0.0086 < 0.0001 - 2.78 2.72 4.35 - [1.36 ; 5.67] [1.29 ; 5.74] [2.39 ; 7.92] Multivariate analysis in patients who underwent resection (n= 47)or transplantation (n = 68) for single HCC on cirrhotic liver < 3 cm diameter
  • 30. 2011
  • 31. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years… 3- Cirrhosis or not Cirrhosis ? 4- Within Milan or Beyond ? 5- Comparative results 6- Equity of access to cure with Salvage ?
  • 32. Salvage transplantation : the solution ?
  • 33. Resection as a bridge to LT 2 different situations… Decision LT Resection LT « Bridge » LT « Salvage » LT Resection 1st Recurrence LT
  • 34. Resection and Salvage LT ? Adam and coll, Ann Surg 2003 Overall Survival Disease-free Survival
  • 35. Belghiti et al, Ann Surg 2003 Resection as a Bridge / Salvage to LT ? Cherqui et al, Ann Surg 2009 Bridge Salvage
  • 36. Log rank p= 0.17 73% 70% 68% 53% 84% 88% Primary LT : 349 Secondary LT : 33 Secondary vs Primary Transplantation for HCC Overall Survival
  • 37. Secondary vs Primary Transplantation for HCC Disease-free Survival Log rank p= 0.015 70% 51% 65% 43% 81% 75% Primary LT : 349 Secondary LT : 33
  • 38. Yes because: More technical challenging Increased risk of recurrence Decreased disease-free survival Liver Resection: a risk for secondary LT ?
  • 39. Is recurrence after Resection always suitable for Transplant ?
  • 40. Resection 2nd LT 1st LT Decision LT Decision LT Drop out Recurrence Out of Milan criteria Life-threatening GI Bleeding Infected Ascites Liver Failure Drop out CANDIDATES ELECTED
  • 41. Author Adam Margarit DelGaudio Cherqui Fucks Present S Country France Spain Italy France France France Year 2003 - 2008 2009 2010 2011 Res / Rec 98 /75 37 80 / 39 67 / 36 118 / 90 117/ 91 % LT 23% 27% 26% 61% 43% 36% LT after Liver resection : A low transplantability rate overall…
  • 42. From 1996 to 2005, we treated 227 cirrhotic patients with HCC transplantable: 80 LRs and 147 LTs of 293 listed for transplantation. Among 80 patients eligible for transplantation who underwent LR, 39 (49%) developed HCC recurrence and 12/39 (31%) of these patients presented HCC recurrence outside Milan criteria. Only 10 of the 39 patients underwent LT, a transplantation rate of 26% of patients with HCC recurrence. 26% Transplantability rate of recurrence ! 12.5% Transplantability rate of all LR !
  • 43. Transplantability rate is much lower in practice than it is theoretically expected : Up to 50% of patients could loose the chance to be transplanted… Transplantability after Resection The reality…
  • 44. « This low salvage rate may represent a lost opportunity for a number of patients who, had they received a primary transplant may have had better long term survival. For these patients the potential for cure has been lost » « Therefore, if we are going to propose resection to the patient with HCC and cirrhosis we are potentially treating the patient with an option that gives this patient a greater chance of recurrence and a questionable overall survival when compared to primary liver transplantation »
  • 45. Resection with possible LT vs Primary LT Overall Survival 68% 59% 56% 32% 88% 84% Log rank test, p<0.0001 Primary LT : 352 Primary resection ± LT : 115 From the time of LR From the time of LT
  • 46. Resection with possible LT vs Primary LT Disease-free Survival at last follow up 65% 31% 54% 20% 82% 70% Log rank test, p<0.0001 Primary LT : 352 Primary resection ± LT : 115
  • 47. Multivariate Analysis on Patients Eligible for Transplant Resected or Transplanted (n=466) RRP IC 95% Overall survival Disease-free survival No nodules > 3 2.030.0008 Max size > 30 mm 1.710.002 [1.34 ; 3.08] [1.22 ; 2.40] Resection + LT 1.910.02 [1.11 ; 3.28] No nodules > 3 1.710.02 Max size > 30 mm 1.770.002 [1.09 ; 2.67] [1.24 ; 2.52] Resection + LT 1.910.02 [1.11 ; 3.28]
  • 48. What are the Keys of Decision ? 1- DFS more than OS… 2- Survival at 10 years more than at 5 years… 3- Cirrhosis or not Cirrhosis ? 4- Within Milan or Beyond ? 5- Comparative results 6- Equity of access to cure with Salvage ? 7- Could organ shortage justify all strategies ?
  • 49. Shortage of Organs… 1- A living donor could sometimes be available… 2- Even not available, results of LT for HCC within Milan criteria are as good as that of Benign disease So…. Why to penalize patients with transplantatble HCC precluding 80% of them from a possibility of long term survival if not cure ?… Yes but…
  • 50. et al
  • 51. CONCLUSIONS 1- Although liver resection may provide good survival benefit to hyperselected patients, LT is overall the best option at long term and on a disease-free basis 2- Resection provides similar survival only for single HCC< 3 cm with however a lower disease-free survival compared to LT 3- Salvage transplantation is not the solution since a significant proportion of pts loose the chance to be transplanted… 4- Provided that the survival benefit of HCC patients is similar to that of ESLD, there is no ethical reason to discriminate HCC…